Vial Fill-Finish CDMOs

Forge Biologics (Ajinomoto Group)

United States

Forge Biologics, acquired by Ajinomoto Group in 2023 for $554-620 million, is a gene therapy CDMO specializing in high-purity adeno-associated virus (AAV) vector and plasmid manufacturing. The company operates a 200,000 sq ft Hearth facility in Columbus, Ohio with 20 cGMP suites and 20,000L bioreactor capacity, providing end-to-end services from preclinical process development through commercial manufacturing.

Global Pharma HealthCare (India)

India

Global Pharma HealthCare is an Indian pharmaceutical CDMO offering contract development and manufacturing services for sterile and non-sterile dosage forms. The company provides end-to-end services from formulation development through commercial manufacturing, including oral solids, liquids, sterile injectables, and lyophilized products. It serves regulated markets including the US, EU, and other global markets.

GP Pharm S.A.

Spain

GP Pharm S.A. is a Spanish CDMO specializing in sterile injectable manufacturing, with particular expertise in long-acting injectable depot formulations including microspheres and sustained-release systems. The company offers contract development and manufacturing services from formulation development through commercial production, with capabilities in aseptic processing, fill/finish for vials and pre-filled syringes, and lyophilization.

Grand River Aseptic Manufacturing (GRAM)

United States

Grand River Aseptic Manufacturing (GRAM) is a premier US-based CDMO specializing exclusively in sterile injectable fill-and-finish services for liquid and lyophilized vials, pre-filled syringes, and cartridges. The company serves pharmaceutical and biotech clients with capabilities spanning clinical through commercial-scale production for biologics, small molecules, and vaccines. GRAM also partners with drug delivery device innovators to offer solutions for autoinjectors and on-body delivery systems.

Hans Scientific

United States

HANS Scientific is a U.S.-based pharmaceutical contract manufacturing organization headquartered in Farmington Hills, Michigan, with a $2 billion investment in expanding its 27-acre manufacturing campus. The company specializes in fill/finish with terminal sterilization, aseptic fill and lyophilization, and Water for Injection (WFI) production using patent-pending technology. It features on-site QA/RA teams and in-house testing capabilities.

Help S.A. (HELP Pharmaceuticals)

Greece

HELP Pharmaceuticals is a Greek pharmaceutical company founded in 1971, operating an EU-GMP certified production facility in Ioannina, Greece. The company manufactures pharmaceuticals, medical devices, nutraceuticals, and cosmeceuticals across sterile and non-sterile lines, including solid, liquid, and semi-solid dosage forms. HELP serves partners in more than 50 countries and provides clinical manufacturing and packaging services.

Hitech Health

Ireland

HiTech Health is an Irish CDMO specializing in GMP sterile manufacturing for advanced therapies including cell and gene therapies. The company provides clinical-scale aseptic fill-finish of vials and bags, Qualified Person (QP) release services for EU and UK markets, regulatory support, and end-to-end supply chain management. HiTech Health recently opened a new advanced therapy manufacturing center in Galway, Ireland.

INCOG Biopharma Services

United States

INCOG BioPharma Services is a US-based CDMO headquartered in Fishers, Indiana, providing end-to-end solutions for sterile injectable drug products from clinical through commercial phase. The company operates a purpose-built, FDA-approved and Annex 1-compliant facility with state-of-the-art fill/finish capabilities and is undergoing a $200 million expansion to boost production capacity.

Kemwell Biopharma Private Limited

India

Kemwell Biopharma is one of India's largest biologics CDMOs, providing integrated drug substance and drug product development and manufacturing services from a single site in Bangalore. Established with technological support from a leading German biopharmaceutical company, Kemwell serves global pharma and biotech organizations with capabilities spanning monoclonal antibodies, complex fusion proteins, recombinant proteins, and bispecific antibodies. The company has received U.S. FDA approval for commercial drug product manufacturing and operates hybrid biomanufacturing with both stainless steel and single-use bioreactor systems.

Kindeva Drug Delivery

United Kingdom

Kindeva Drug Delivery is a leading global drug-device combination CDMO specializing in sterile injectables, pulmonary and nasal inhalation, and dermal/transdermal drug delivery platforms. The company has a history spanning back to 1956 when it invented the pressurized metered-dose inhaler (pMDI). Kindeva operates a global network of 10 manufacturing and R&D sites including a 155,000+ sq ft dedicated aseptic operations facility in Bridgeton. They hold 12 FDA-approved products across aerosol, metered-dose, film, and extended release dosage forms. Their FDA record shows 38 inspections (9 NAI, 22 VAI, 7 OAI) and 6 FEI-registered facilities covering analysis, manufacture, and sterilization.

LABIANA

Spain

LABIANA is a Spanish pharmaceutical group founded in 1958 with over 60 years of history, now listed on BME Growth. They operate as a CDMO serving both human and veterinary pharmaceutical sectors. LABIANA has three EU-GMP manufacturing plants: Labiana Pharmaceuticals in Corbera de Llobregat (Barcelona) for human pharma with sterile liquids, non-sterile liquids, and non-sterile solids; and Labiana Life Sciences in Terrassa (Barcelona) plus Veterinarski Zavod Subotica in Serbia for veterinary products including biologicals (viral, bacterial, and autogenous vaccines). The company is a benchmark in contract manufacturing for sterile forms and also manufactures/distributes Fosfomycin Trometamol under its own brand. Their subsidiary Zoleant Pharmaceuticals handles global marketing of niche alternative brand medicines.

Laboratório Edol, S.A.

Portugal

Laboratorio Edol, S.A. is a Portuguese pharmaceutical company specializing in development, manufacturing, and marketing of medicines, medical devices, cosmetics, and food supplements, with a focus on Ophthalmology, Dermatology, Otorhinolaryngology, and Dermocosmetics. They operate from their factory in Linda-a-Velha, Portugal and offer contract manufacturing (producao para terceiros) services across a wide range of pharmaceutical forms including small and large volume injectables, gels, creams, ointments, syrups, oral solutions and suspensions, cutaneous solutions, and enemas. They have two industrial units equipped for third-party manufacturing.

Landmark Bio

United States

Landmark Bio is a cell and gene therapy CDMO based in Watertown, MA, focused on the development and manufacturing of advanced therapies. Offers end-to-end services including process and analytical development, formulation development, cGMP manufacturing, fill/finish, quality control testing, CMC consulting, and IND-enabling services. Acquired by Artis BioSolutions (a new genetic medicines CDMO) to form a comprehensive advanced therapy manufacturing platform. Facility is a 44,000 sq ft full-spectrum manufacturing site.

Lifecore Biomedical

United States

Lifecore Biomedical (Nasdaq: LFCR) is a fully integrated CDMO headquartered in Chaska, Minnesota, specializing in sterile injectable drug product development and manufacturing. The company has over 40 years of experience in aseptic fill/finish, with particular expertise in highly viscous formulations. Lifecore is also a premium producer of non-animal-sourced sodium hyaluronate.

Made Scientific

United States

Made Scientific is a US-based cell therapy CDMO specializing in development and GMP manufacturing of cell-based therapies including T cells, NK cells, HSCs, MSCs, iPSCs, and TILs. The company provides services from pre-clinical support through Phase I-III clinical trials and commercial enablement, including process and analytical development, GMP cell banking, drug product manufacture, aseptic fill and finish, and QC lot release and stability testing. FDA-registered with FEI number and operations including API manufacture, analysis, labeling, manufacturing, and packaging.

Magle Chemoswed AB

Sweden

Magle Chemoswed AB is a Swedish CDMO serving pharmaceutical and medical device companies with comprehensive services from development through manufacturing on a contract basis. The company operates a full cGMP and ISO 13485 production site in Malmo with five dedicated manufacturing suites. Services include analytical development, process development, solid state characterization, freeze drying (lyophilization), small-scale vial fill and finish, and inhalation drug product development. FDA inspected (3 inspections: 1 NAI, 2 VAI).

MAKCUR LABORATORIES LTD.

India

MAKCUR LABORATORIES LTD. is an Indian pharmaceutical manufacturer specializing in small volume parenterals (liquid vials/ampoules), powder injections, and ophthalmic/otic drops. The company manufactures a range of finished dosage forms including antibiotics, anti-inflammatory, antifungal, and ophthalmic preparations. Products include branded formulations in eye/ear drops, liquid injections, and topical preparations. Located in Naroda-Dehgam, Gujarat, India.

medac GmbH (medac CDMO)

Germany

medac GmbH operates a dedicated CDMO division (medac CDMO) offering end-to-end sterile injectable manufacturing services from clinical supply through large-scale commercial production. Based in Germany with facilities in Wedel and Dessau (Germany) and Brno (Czech Republic), medac specializes in small molecules, biologics (mAbs, proteins, peptides, oligonucleotides), and ADCs. They handle aseptic filling, terminal sterilization, lyophilization, and high-potent API processing down to OEL = 10 ng/m3. Manufacturing scales range from 1-50 L (small) to 50-1,500 L (large) with campaigns up to 11,000 L. They partner with Cerbios under the PROVEO brand for integrated ADC services. Over 40 years of regulatory expertise with approvals from multiple international health authorities.

Microbiosci (Creative Biogene)

United States

Microbiosci (Creative Biogene) is a US-based biotech CDMO specializing in microbial fermentation-based production of commercial biological substances. The company provides GMP manufacturing services for recombinant proteins, recombinant pharmaceutical proteins, monoclonal antibodies, nucleic acid drugs, APIs, peptides, microbial metabolites, and enzymes. Their integrated platform includes strain development, fermentation process development, upstream/downstream processing, and fill-finish services.

Northway Biotech

Lithuania

Northway Biotech is a global end-to-end biologics CDMO specializing in protein-based biologics and gene therapies. The company operates state-of-the-art facilities in Vilnius, Lithuania (EU) and Waltham, Massachusetts (US), with 20+ years of technical expertise. Northway offers cell line development, process development, analytical development, and cGMP manufacturing of drug substances and drug products using both mammalian cell culture and microbial fermentation technologies.

NorthX Biologics

Sweden

NorthX Biologics is a Swedish CDMO specializing in advanced biologics and ATMPs (Advanced Therapy Medicinal Products). The company offers end-to-end services from process development to GMP manufacturing for recombinant proteins, viral vectors, plasmid DNA, cell therapy, extracellular vesicles, and mRNA. Recognized by the Swedish Government as an international competence center and innovation hub in 2021, NorthX has 30+ years of GMP manufacturing experience.

Omisan Farmaceutici SRL

Italy

Omisan Farmaceutici SRL is an Italian company specializing in the development, production, and commercialization of sterile medical devices for ophthalmic care. The company offers private label and contract manufacturing (CDMO) services and is the official manufacturer for several leading multinational ophthalmic companies, with products distributed in more than 40 countries.

OneSource Specialty Pharma Limited

India

OneSource Specialty Pharma Limited (formerly Stelis Biopharma Limited) is India's first specialty pharma pure-play CDMO, offering multimodal end-to-end capabilities across drug-device combinations, complex sterile injectables, biologics, and soft gelatin capsules. The company operates five state-of-the-art facilities in Bengaluru with 35 approved ANDAs and 19 commercialized drug products in the US market.

Oxford Biomedica (OXB)

United Kingdom

Oxford Biomedica (OXB) is a global, quality- and innovation-led CDMO specializing in viral vector development and manufacturing for cell and gene therapy. With 25+ years of experience, OXB is the first and currently only FDA-approved CDMO for commercial production of lentiviral vectors for CAR-T therapy. The company operates GMP suites across three countries with extensive end-to-end capabilities in lentivirus, AAV, and adenovirus vectors.

Pharmaceutical Solutions Industry (PSI)

Saudi Arabia

Pharmaceutical Solutions Industry (PSI) is a leading injectable manufacturer in the Middle East and Africa, based in Saudi Arabia. The company manufactures standard IV solutions including dialysis solutions, pain management products, and large volume parenterals for the pharmaceutical industry.

Pharmapac (UK) Ltd

United Kingdom

PharmaPac UK Ltd is a Contract Manufacturing Organisation (CMO) that specialises in the manufacture and packaging of a variety of drug delivery systems. The company provides pharmaceutical manufacturing, filling, and packing services for medicinal products. With 150+ employees and led by a General Manager, the company has capabilities in injectable packaging and contract manufacturing. No website data was available for detailed capability analysis.

Quotient Sciences

United Kingdom

Quotient Sciences is a UK-headquartered pharmaceutical CRDMO (contract research, development, and manufacturing organization) specializing in small molecule and synthetic peptide drug product development and manufacturing. They offer integrated formulation development, clinical manufacturing, and commercial production, with their proprietary Translational Pharmaceutics approach integrating clinical activities with real-time cGMP manufacturing. They have facilities in the US and UK, with capabilities including HPAPI manufacturing, sterile fill/finish, and oral solid dose.

Recipharm AB

Sweden

Rechon Life Science AB is a subsidiary/entity within the Recipharm group, the global CDMO headquartered in Stockholm, Sweden. This entry represents the same Recipharm organization (same website: recipharm.com) with its extensive global manufacturing footprint of 15+ FDA-registered FEI numbers and 52 FDA inspections. The Perplexity research confirms Recipharm's specialization in oral solid dose, inhalation, sterile manufacturing, and HPAPI capabilities. Rechon may represent a specific Recipharm site or legacy entity. Duplicate of Recipharm AB entry -- capabilities are identical.

REMEDICA LTD

Cyprus

REMEDICA is a Cyprus-based pharmaceutical manufacturer that has been operating for over four decades, distributing products in more than 160 countries. They manufacture generics across multiple therapeutic areas and dosage forms (solid oral dose, liquids, semi-solids, sterile injectables) and offer contract manufacturing (CMO/CDMO) services. They have long-standing relationships with NGOs (UNICEF, WHO, UNRWA). They focus on B2B partnerships, own-brand commercialization (Cyprus, Eastern EU, Asia, Middle East, Africa, LATAM), and NGO supply.

Rezon Bio

Poland

Rezon Bio is a European biologics CDMO headquartered in Poland, specializing in mammalian drug substance development and GMP manufacturing. The company operates two FDA-approved facilities with mirrored capabilities, employs approximately 1,300 people (10% PhDs), and has 16 years of biologics development experience. Rezon Bio offers end-to-end services from cell line development through commercial manufacturing with 2,000L bioreactors.

Rommelag CDMO GmbH (Rommelag Pharma Service)

Germany

Rommelag CDMO GmbH (Rommelag Pharma Service) is a German company that invented Blow-Fill-Seal (BFS) technology for aseptic packaging of liquid pharmaceutical products. The CDMO division provides contract filling services and product development support for liquid and semi-solid pharmaceutical products using BFS technology. Rommelag also manufactures the bottelpack BFS filling machines (up to 37,500 containers/hour) and provides comprehensive lifecycle services including qualification, validation, and factory planning.

SCTbio

Czechia

SCTbio is a Czech CDMO specializing in cell and gene therapy (ATMP) manufacturing, spun out from SOTIO. The company provides cGMP production of cell-based therapies and retroviral/lentiviral vectors from its 2,000 sqm facility in Prague, Czech Republic. SCTbio has specialized expertise in dendritic cell therapeutics, CAR-T, and viral vector production, supported by a global network of 150 apheresis collection centers.

Selkirk Pharma

United States

Selkirk Pharma is a US-based sterile fill/finish contract manufacturing organization (CMO) located in Spokane, Washington. Purpose-built by fill/finish industry experts, Selkirk offers liquid-filled vial manufacturing (0.5mL to 50mL) with fully automated isolator filling, achieving >99% yield. The facility is harmonized for GMP regulatory compliance with US FDA and EU Annex 1 standards, with capacity for both clinical trials and commercial-scale production.

SGS

Brazil

SGS Integrated CDMO Solutions is the contract development and manufacturing division of the global testing and inspection company SGS SA. Established in 2002 with a specialized UK-based CDMO site (MHRA and FDA inspected), SGS provides formulation development, API manufacturing, sterile fill/finish, lyophilization, and analytical services. A new 55,000 sq ft cGMP facility in Hudson, NH expands their North American capabilities across Phase I-III clinical trials and commercial supply.

Sharp Sterile Manufacturing

United States

Berkshire Sterile Manufacturing (now Sharp Sterile Manufacturing, acquired by Sharp in 2023) is a specialist CDMO providing sterile injectable development and manufacturing services from its isolator-based facility in Lee, Massachusetts. All fills are 100% isolator-based using Colanar fillers, supporting clinical through small-to-mid-scale commercial production of vials, syringes, and cartridges. FDA-inspected with 8 inspections (7 NAI, 1 VAI), demonstrating strong regulatory compliance.

Siegfried Group

China

Siegfried Group is a leading global CDMO with 150+ years of pharmaceutical and chemical heritage, operating 13 production sites across Switzerland, Germany, Spain, France, Malta, the USA, and China. The company provides integrated services from early-phase API development through commercial-scale drug substance and drug product manufacturing, including exclusive synthesis, generic APIs, controlled substances, HPAPI handling, sterile formulations, and viral vector manufacturing through subsidiary DINAMIQS. In January 2026, Siegfried announced acquisition of additional US-based small molecule drug substance capacity.

Singota Solutions

United States

Singota Solutions is a CDMO based in Bloomington, Indiana, focused on aseptic injectable drug development and manufacturing for pharmaceutical, animal health, and biotechnology clients. They specialize in small-batch aseptic filling using the gloveless robotic SA25 Aseptic Filling system (first commercial site in North America). Services include aseptic manufacturing of small volume parenterals (vials, syringes, cartridges), QC testing, formulation and method development, labeling and kitting, and supply chain management including GMP-compliant warehousing and cold chain storage. They recently expanded into Europe with a GDP-certified facility in Balerna, Switzerland.

SMC Ltd.

Costa Rica

SMC Ltd. is a global contract manufacturer headquartered in Costa Rica with over 35 years of experience in medical device contract manufacturing and pharma services. The company offers end-to-end capabilities from device design through commercialization, including sterile fill/finish, analytical services, and drug delivery platform technologies. All facilities are FDA-registered and ISO 13485-certified.

Solupharm GmbH

Germany

Solupharm Pharmazeutische Erzeugnisse GmbH is a German family-owned contract manufacturer specializing in sterile parenteral preparations in glass ampoules and glass vials since 1974. The company operates one of the most modern production facilities in Europe in Melsungen, Germany. Solupharm is FDA-registered as both an API and FDF manufacturer.

STC Biologics

United States

STC Biologics, Inc. is a boutique turn-key biologics CDMO located in Newton, Massachusetts, USA, founded in 2009. The company provides full CMC services and consulting to enable partners to advance biologic products from discovery to commercialization. Their team brings expertise from Genentech, Novartis, Shire, EMD Serono, Lonza, Alexion, and Merrimack. STC offers a Speed-To-Clinic Platform for monoclonal antibodies that can go from royalty-free cell line development directly to cGMP manufacturing and released drug substance within 12 months. They opened a single-use mammalian GMP facility in 2019 and have filed 8+ BLAs, dozens of INDs, and 20+ comparability protocols. They also developed their own biosimilar product, STC101.

The Vanguard Utility Corporation

United States

US-based company using next-generation Blow-Fill-Seal equipment and prefabricated robotic packaging lines to fill-finish generic injectable medicines. Operational subsidiary of ApiJect. Two business approaches: (1) producing compounded pharmaceutical products for the US market through its Global Pharmacy Reserve division, and (2) licensing prefabricated fill-finish lines with their technology to pharma companies globally (Pharmaceutical Reserve Network). Focused on addressing drug shortages of generic injectables. Headquartered in Stamford, CT with operations in Newtown, PA. FDA-registered with 1 NAI inspection.

Torbay Pharmaceuticals (Torbay Pharma)

United Kingdom

Torbay Pharma is a UK-based global CMO and licence holder specializing in contract manufacturing of terminally sterilized generic injectables. The company partners with the world's best-known pharmaceutical companies to manufacture and supply sterile injectable products to more than 20 countries. Services include sterile fill-finish (ampoules, glass/plastic vials, oral syringes), QP certification, labeling/packaging, TPN compounding, and product safety.

Vector BioMed

United States

Vector BioMed is a U.S.-based public benefit corporation and CDMO specializing in lentiviral vector design and manufacturing for cell and gene therapies. Launched following $15M in funding, the company provides essential lentiviral vector capabilities using their proprietary LENTIVERSE platform. They produce high-titer (>10^9 TU/mL) lentiviral vectors using a serum-free, chemically-defined process. Key differentiators include algorithm-optimized vector design, rapid turnaround (months from onboarding to GMP batch release), modular pre-validated systems to reduce costs and avoid royalty-based constraints, and a focus on making advanced therapies accessible in lower-resource settings. They partner with CIRM (California Institute for Regenerative Medicine) on lentiviral vector manufacture.

Advaxia Biologics is a CDMO near Rome, Italy, specializing in adenovirus vaccine development and cGMP manufacturing. With over 10 years of biologics expertise and a 100% batch approval rate, Advaxia provides fully integrated services from expression systems and process development to analytical development and GMP manufacturing, and is EMA, FDA, and AIFA compliant.

Contract Packaging Resources is a member of the Aenova Group, a worldwide leading CDMO for the pharmaceutical and healthcare industry. The Aenova Group provides comprehensive pharmaceutical manufacturing including solid dosage forms, sterile fill and finish, semi-solids, non-sterile liquids, softgels, gummies, and packaging services. The Latina site in Italy serves as the central sterile manufacturing facility with capacity for over 100 million units per year, handling biologics including monoclonal antibodies, peptides, and vaccines with isolator technology.

AMPAC Analytical is part of SK pharmteco, a major integrated CDMO providing custom small molecule API development and manufacturing, viral vector and gene therapy CDMO services, and comprehensive analytical testing. SK pharmteco operates FDA/EMA/PMDA-inspected facilities across the US, Korea, Ireland, and France with capabilities spanning from clinical trials through commercial scale manufacturing.

Bushu Pharma is Japan's premier CDMO with over 25 years of experience, specializing in contract manufacturing of solid dosage formulations, sterile injectables, lyophilized products, and prefilled syringes for both clinical trial supplies and commercial products. The company operates five factories in Japan with GMP certifications from 56 countries including FDA, EMA, and PMDA, serving over 90 pharmaceutical companies globally with nearly 50% of sales from foreign-affiliated clients.

Caplin Point Laboratories is a fully integrated Indian pharmaceutical company with a dominant presence in Latin America and Francophone Africa, and a growing presence in the US and EU. Through its subsidiary Caplin Steriles, the company manufactures sterile injectables, ophthalmic products, pre-mix bags, and pre-filled syringes, with 46 FDA-approved products.